CHUNLI MEDICAL(SH:688236) Shang Hai Zheng Quan Bao·2026-02-27 21:29Financial Performance Summary - The company reported a total operating revenue of 1,043,768,680.27 yuan, representing a year-on-year increase of 29.52% [2] - The net profit attributable to the parent company reached 272,124,670.05 yuan, showing a significant year-on-year growth of 117.72% [2] - Total assets at the end of the reporting period amounted to 3,659,165,538.06 yuan, an increase of 5.58% compared to the beginning of the period [2] - The equity attributable to the parent company was 2,985,050,158.61 yuan, reflecting a growth of 5.86% from the start of the period [2] - The earnings per share attributable to the parent company increased to 7.78 yuan, up by 5.86% [2] Key Growth Drivers - The growth in operating profit, total profit, and net profit attributable to the parent company was primarily driven by the normalization of national centralized procurement for orthopedic consumables, which enhanced product sales and market share [3] - The company has been advancing its internationalization strategy, achieving continuous expansion in overseas markets, which has significantly contributed to overall performance growth [3] - Operational efficiency and profitability have improved due to refined management practices and economies of scale from increased production [3]